Ashley Cordova
Net Worth

Last updated:

What is Ashley Cordova net worth?

The estimated net worth of Ms. Ashley Cordova is at least $8,218,972 as of 2 Nov 2023. She owns shares worth $1,201,679 as insider, has earned $2,041,293 from insider trading and has received compensation worth at least $4,976,000 in NovoCure Limited.

What is the salary of Ashley Cordova?

Ms. Ashley Cordova salary is $995,200 per year as Chief Financial Officer & Vice President of Investor Relations in NovoCure Limited.

How old is Ashley Cordova?

Ms. Ashley Cordova is 46 years old, born in 1979.

What stocks does Ashley Cordova currently own?

As insider, Ms. Ashley Cordova owns shares in one company:

Company Title Shares Price per share Total value
NovoCure Limited (NVCR) Chief Financial Officer & Vice President of Investor Relations 99,650 $12.06 $1,201,679

What does NovoCure Limited do?

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

NVCR logo
NVCR
NovoCure Limited
$12.06

Ashley Cordova insider trading

NovoCure Limited

Ms. Ashley Cordova has made 17 insider trades between 2020-2023, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 36,624 units of NVCR stock on 12 Aug 2021. As of 2 Nov 2023 she still owns at least 99,650 units of NVCR stock.

Transaction Date Security Shares Price per share Total value Source
Option
Ordinary Shares 175 $11.46 $2,006
Option
Stock Option (Right to Buy) 175 $11.46 $2,006
Option
Ordinary Shares 2,480 $11.44 $28,371
Option
Stock Option (Right to Buy) 7,561 $11.46 $86,649
Option
Stock Option (Right to Buy) 10,232 $9.3 $95,106
Option
Ordinary Shares 7,752 $7.15 $55,427
Option
Ordinary Shares 7,561 $11.46 $86,649
Sale
Ordinary Shares 883 $21.82 $19,264
Sale
Ordinary Shares 1,144 $30.25 $34,607
Sale
Ordinary Shares 775 $76.16 $59,023
Sale
Ordinary Shares 4,730 $76.16 $360,232
Sale
Ordinary Shares 1,055 $75.28 $79,418
Sale
Ordinary Shares 2,198 $76.36 $167,844
Option
Ordinary Shares 2,000 $7.15 $14,300
Option
Options to Buy Ordinary Shares 2,000 $7.15 $14,300
Sale
Ordinary Shares 885 $79.04 $69,948
Sale
Ordinary Shares 759 $70.1 $53,206
Sale
Ordinary Shares 556 $70.41 $39,146
Option
Options to Buy Ordinary Shares 3,840 $15.6 $59,904
Option
Options to Buy Ordinary Shares 1,200 $11.46 $13,752
Option
Ordinary Shares 3,840 $15.6 $59,904
Option
Ordinary Shares 1,200 $11.46 $13,752
Sale
Ordinary Shares 1,149 $74.5 $85,598
Sale
Ordinary Shares 209 $107.28 $22,421
Sale
Ordinary Shares 828 $138.23 $114,456
Sale
Ordinary Shares 5,927 $141.06 $836,063
Option
Ordinary Shares 36,624 $120.04 $4,396,491
Option
Options to Buy Ordinary Shares 36,624 $120.04 $4,396,491
Sale
Restricted Share Units 765 $130.81 $100,067
Sale
Restricted Share Units 567 N/A N/A
Sale
Restricted Share Units 428 N/A N/A
Option
Ordinary Shares 1,465 N/A N/A
Option
Restricted Stock Units 1,465 N/A N/A
Sale
Ordinary Shares 230 N/A N/A

NovoCure Limited key executives

NovoCure Limited executives and other stock owners filed with the SEC: